CLINICAL_TRIALS
trial_result
· 2018-11-23
Clinical Trial Update: A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache [Phase 2]
Summary
Phase 2 clinical trial update for galcanezumab (LY2951742) in participants with migraine headache; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED | Results posted: 2018-11-23